Pedro A. Lemos, MD

Pedro A. Lemos , MD;

Georgios Sianos , MD, PhD;

Effectiveness of the Sirolimus-Eluting Stent in the Treatment of Saphenous Vein Graft Disease

ABSTRACT: Background. Recurrent restenosis following vascular brachytherapy (VBT) has been reported in up to one-third of the patients enrolled in clinical trials. The long-term outcome of repeat percutaneous intervention (PCI) after failed...

ABSTRACT: Background. Recurrent...

08/01/2008

Journal of Invasive Cardiology

08/01/2008

Francesco Saia , MD, PhD;

Pedro A. Lemos , MD;

Chourmouzios A. Arampatzis , MD;

Muzaffer Degertekin , MD;

Sjoerd H. Hofma , MD;

Eugene P. McFadden , MB, MD;

Georgios Sianos , MD, PhD;

Pieter C. Smits , MD, PhD;

Kengo Tanabe , MD;

Treatment of Coronary Artery Disease in Dialysis Patients with Sirolimus-eluting Stents: 1-year Clinical Follow-up of a Consecut

ABSTRACT: The use of bare stents for the percutaneous intervention of saphenous vein bypass grafts (SVGs) is associated with a high subsequent rate of restenosis. To assess the impact of the sirolimus-eluting stent (SES), we studied 19...

ABSTRACT: The use of bare stents...

08/01/2008

Journal of Invasive Cardiology

08/01/2008

Joost Daemen , MD, PhD;

Jiro Aoki , MD;

Pedro A. Lemos , MD;

Predictors of Survival After Contemporary Percutaneous Coronary Revascularization for Acute Myocardial Infarction in the Real Wo

Chourmouzios A. Arampatzis , MD;

Eugene P. McFadden , MB, MD;

In this preliminary series, sirolimus-eluting stent implantation appeared safe and effective for the treatment of dialysis patients with coronary artery disease. Dialysis patients are well known to be a high-risk population for cardiovascular...

In this preliminary series,...

08/01/2008

Journal of Invasive Cardiology

08/01/2008

Pieter C. Smits , MD, PhD;

Kengo Tanabe , MD;

Chi-Hang Lee , MD, MBBS, MRCP;

Pedro A. Lemos , MD;

Sirolimus-eluting Stents for the Treatment of Atherosclerotic Ostial Lesions

Management strategies for ST-elevation myocardial infarction (STEMI) have undergone great evolution over the past decade. Currently, primary mechanical reperfusion is considered superior to thrombolytic therapy in achieving complete and...

Management strategies for...

08/01/2008

Journal of Invasive Cardiology

08/01/2008

Sjoerd H. Hofma , MD;

Eugene P. McFadden , MB, MD;

Georgios Sianos , MD, PhD;

Pieter C. Smits , MD, PhD;

Jiro Aoki , MD;

Gaston A. Alfredo Rodriguez-Granillo , MD;

Andrew T.L. Ong , MD, MBBS, PhD;

Maniyal Vijayakumar ;

Successful Use of a New Guidewire with Radiofrequency Ablation Capability for the Treatment of Chronic Total Occlusion at the Os

Pedro A. Lemos , MD;

Ostial atherosclerotic lesions constitute a distinct substrate for percutaneous interventions, as they differ from the other lesion sites in management strategies and in clinical outcomes. Since the lesions are more likely fibrotic and...

Ostial atherosclerotic lesions...

08/01/2008

Journal of Invasive Cardiology

06/19/2008

Pedro A. Lemos , MD;

Successful Use of a New Guidewire with Radiofrequency Ablation Capability for the Treatment of Chronic Total Occlusion at the Os

The major limitation of percutaneous therapy (PCI) for the treatment of chronic total occlusions (CTOs) is the inability to cross with a wire. We report successful recanalization of a CTO situated at the ostium of the left anterior descending...

The major limitation of...

06/19/2008

Cath Lab Digest

Feature

06/19/2008

Pedro A. Lemos , MD;

Successful Use of a New Guidewire with Radiofrequency Ablation Capability for the Treatment of Chronic Total Occlusion at the Os

The major limitation of...

06/19/2008

Cath Lab Digest

Case Report

08/01/2008

Pedro A. Lemos , MD;